JOHN NORTON: Open Payments
NPI 1124060033 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 14 payments from 6 companies in 2025. Trend: 2023 $20,312 · 2024 $338 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $124 |
| Alkermes, Inc. | 5 | $119 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
| Neurocrine BioSciences, Inc. | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Lundbeck LLC | 1 | $19 |
Products named: Auvelity, ARISTADA, COBENFY, INGREZZA, ABILIFY ASIMTUFII, UZEDY, AUSTEDO XR.
Industry payments across MS — which companies pay providers there.
